Join a groundbreaking study to find a once-a-month PrEP pill.
We’re looking for people to join a research study to test an investigational PrEP pill you only have to take once a month. Researchers want to learn about an investigational medicine called MK-8527 to see whether it may help prevent HIV-1 in trans and gender-diverse people who are taking gender-affirming hormone therapy.
Study participation will include sexual health screenings, taking oral medication once a month for 3 months, and getting blood draws at our office in San Francisco (Civic Center). If you meet the requirements and decide to join, you will be in the trial for about 7 months and visit the trial site 7 times.
You may be eligible to participate if you are:
• HIV negative,
• Identify as a transgender or non-binary person
• Are currently taking gender affirming hormones,
• Do not have multiple sex partners,
• and are not currently taking daily PrEP.
Eligible participants can receive up to $125 per visit after screening.